OR WAIT null SECS
© 2021 MJH Life Sciences and BioPharm International. All rights reserved.
© 2021 MJH Life Sciences™ and BioPharm International. All rights reserved.
September 22, 2021
Lonza’s investment in its Stein and Basel facilities in Switzerland aims to expand its overall drug product development and manufacturing services.
August 31, 2021
USAntibiotics will serve as the sole American-based provider of amoxicillin and amoxil clavulanate.
August 17, 2021
Syngene’s additions include a new microbial facility and an expanded mammalian facility.
August 13, 2021
Recro acquires CDMO IRISYS, establishing a bi-coastal presence in the US.
August 12, 2021
Veraxa and Indivumed will work together to develop colorectal antibody drugs.
August 06, 2021
Syngene International appoints two US-based executives to senior level positions.
July 30, 2021
VICO Therapeutics’ drug candidate, VO659, for treating Huntington’s Disease was granted orphan drug designation by FDA.
July 16, 2021
Kriya Therapeutics completes $100 Million Series B financing to advance its platform for designing, developing, and manufacturing gene therapies.
May 10, 2021
BioNTech plans to expand its global footprint by establishing its regional headquarters for southeast Asia and a new mRNA manufacturing facility in Singapore.
March 30, 2021
The expanded agreement will include aseptic fill/finish services at its San Diego, CA facility.